[ad_1]
SHANGHAI, Nov. 4, 2024 /PRNewswire/ — 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a important tech-enabled healthcare platform corporate dedicated to reshaping the price chain of healthcare trade by way of digitally empowering the upstream and downstream in China, lately introduced that Dr. Leon Lian Yong Chen has tendered his retirement from the location because the Corporate’s director for private causes, high quality on November 4, 2024. The board has additionally appointed Mr. Yang “Luke” Chen, lately serving because the Corporate’s Senior Finance Govt, as a fresh director, high quality November 4, 2024.
Dr. Lian Yong Chen has served at the board of administrators of the Corporate since Would possibly 2019. “I am grateful to Dr. Chen for his significant contributions during his term of office. His knowledge and advice have been invaluable in propelling our goals and strategies for long-term achievements. On behalf of the board, I extend best wishes to Dr. Chen and look forward to further collaborating with him in the future,” stated Mr. Gang Yu, Co-Founder and Govt Chairman of the Corporate.
In regards to the appointment of Mr. Yang “Luke” Chen, Mr. Gang Yu added, “We are delighted to welcome Luke to our board of directors. His extensive financial expertise and deep understanding of our business will be instrumental as we continue to drive our strategic initiatives forward. I am confident that his leadership and insights will contribute to our ongoing success and growth.”
Ahead-Having a look Statements
This press loose comprises forward-looking statements. Those statements represent “forward-looking” statements inside the that means of Category 21E of the Securities Alternate Operate of 1934, as amended, and as outlined within the U.S. Personal Securities Litigation Reform Operate of 1995. Those forward-looking statements may also be recognized by way of terminology corresponding to “will,” “expects,” “anticipates,” “future,”” “intends,” “plans,” “believes,” “estimates,” “goal,” “assured” and matching statements. 111 may additionally manufacture written or oral forward-looking statements in its periodic studies to the U.S. Securities and Alternate Fee, in its annual report back to shareholders, in press releases and alternative written fabrics and in oral statements made by way of its officials, administrators or workers to 3rd events. Such statements are founded upon control’s wave expectancies and wave marketplace and working situations and relate to occasions that contain identified or unknown dangers, uncertainties and alternative components, all of which might be tricky to are expecting and lots of of which might be past the Corporate’s keep an eye on. Ahead-looking statements contain inherent dangers, uncertainties and alternative components that might purpose fresh effects to fluctuate materially from the ones contained in this sort of statements. Possible dangers and uncertainties come with, however aren’t restricted to, uncertainties as to the Corporate’s talent conform to in depth and evolving regulatory necessities, its talent to compete successfully within the evolving PRC basic fitness and wellness marketplace, its talent to govern the expansion of its trade and enlargement plans, its talent to reach or conserve profitability going forward, its talent to keep an eye on the dangers related to its pharmaceutical retail and wholesale companies, and the Corporate’s talent to fulfill the criteria essential to conserve record of its ADSs at the Nasdaq International Marketplace, together with its talent to recovery any non-compliance with Nasdaq’s endured record standards. Additional knowledge referring to those and alternative dangers, uncertainties or components is integrated within the Corporate’s filings with the U.S. Securities and Alternate Fee. All knowledge equipped on this press loose is as of the era of this press loose, and 111 does no longer adopt any legal responsibility to replace any forward-looking commentary because of fresh knowledge, hour occasions or another way, aside from as required below appropriate legislation.
About 111, Inc.
111, Inc. (NASDAQ: YI) (“111” or the “Company”) is a important tech-enabled healthcare platform corporate dedicated to reshaping the price chain of healthcare trade by way of digitally empowering the upstream and downstream in China. The Corporate supplies shoppers with higher get right of entry to to pharmaceutical merchandise and healthcare services and products immediately thru its on-line retail pharmacy, 1 Pharmacy, and not directly thru its offline digital pharmacy community. The Corporate additionally deals on-line healthcare services and products thru its web clinic, 1 Health facility, which supplies shoppers with cost-effective and handy on-line session, digital prescription provider, and affected person control provider. As well as, the Corporate’s on-line platform, 1 Drugs, serves as a one-stop store for pharmacies to supply a giant collection of pharmaceutical merchandise. With the biggest digital pharmacy community in China, 111 permits offline pharmacies to higher provide their consumers with cloud-based services and products. 111 additionally supplies an omni-channel drug commercialization platform to its strategic companions, which contains services and products corresponding to virtual advertising and marketing, affected person training, knowledge analytics, and pricing tracking.
For more info on 111, please seek advice from: http://ir.111.com.cn/.
SOURCE 111, Inc.
WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Virtual Media
Retailers
270k+
Reporters
Opted In
[ad_2]
Source link
